These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2759175)

  • 21. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
    Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
    Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of striatal acetylcholine concentration by dopamine receptors.
    Sethy VH; Van Woert MH
    Nature; 1974 Oct; 251(5475):529-30. PubMed ID: 4421728
    [No Abstract]   [Full Text] [Related]  

  • 24. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain.
    Wong DT; Bymaster FP; Reid LR; Fuller RW; Perry KW; Kornfeld EC
    J Neural Transm; 1983; 58(1-2):55-67. PubMed ID: 6655467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypophysectomy fails to affect the supersensitivity of striatal dopamine target cells induced by prolonged haloperidol treatment.
    Scatton B; Fage D
    Eur J Pharmacol; 1984 Feb; 98(1):1-7. PubMed ID: 6538845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal differences in behavioral effect of fenfluramine and norfenfluramine.
    Schechter MD
    Pharmacol Biochem Behav; 1990 Mar; 35(3):527-31. PubMed ID: 2339144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
    Imazu Y; Kobayashi K; Shohmori T
    Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.